Penn Medicine Abramson Cancer Center


 

UPenn Updates on HER2+ EBC: CT De-Escalation Using F-PET, Adjuvant Trastuzumab Emtansine + Pertuzumab Following Anthracyclines in Operable Primary BC

101 views
December 1, 2020
Comments 0
Login to view comments. Click here to Login